Conditional ablation of MCU exacerbated cardiac pathology in a genetic arrhythmic model of CPVT
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic arrhythmic syndrome caused by mutations in the calcium (Ca2+) release channel ryanodine receptor (RyR2) and its accessory proteins. These mutations make the channel leaky, resulting in Ca2+-dependent arrhythmias. B...
Saved in:
| Main Authors: | Arpita Deb, Brian D. Tow, Jie Hao, Branden L. Nguyen, Valeria Gomez, James A. Stewart, Jr, Ashley J. Smuder, Bjorn C. Knollmann, Ying Wang, Bin Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Journal of Molecular and Cellular Cardiology Plus |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772976124000333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
by: Roshan Paudel, et al.
Published: (2024-11-01) -
Dual calcium-voltage optical mapping of regional voltage and calcium signals in intact murine RyR2-R2474S hearts
by: Yangpeng Li, et al.
Published: (2024-12-01) -
Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling
by: Jinhui Ye, et al.
Published: (2024-12-01) -
Attempts to Create Transgenic Mice Carrying the Q3924E Mutation in RyR2 Ca<sup>2+</sup> Binding Site
by: Xiao-hua Zhang, et al.
Published: (2024-12-01) -
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs
by: Valeria Bettinsoli, et al.
Published: (2025-01-01)